IMNM
Immunome Inc.
Company Overview
| Mkt Cap | $1.37B | Price | $16.07 |
| Volume | 732.91K | Change | +0.56% |
| P/E Ratio | -4.7 | Open | $15.93 |
| Revenue | $9.0M | Prev Close | $15.98 |
| Net Income | $-293.0M | 52W Range | $5.15 - $17.32 |
| Div Yield | N/A | Target | $24.09 |
| Overall | 60 | Value | 55 |
| Quality | -- | Technical | 66 |
No chart data available
Stock Overview
Updated DailyImmunome Inc. (IMNM) is a leading Manufacturing company in the Pharmaceutical Preparation Manufacturing industry, currently trading at $16.07 with a market capitalization of $1.37 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows IMNM with a volume of 733K shares. The stock opened down 0.31% from yesterday's close of $15.98. Current analyst estimates project earnings of $-2.22 per share for this year, with next year targeting $-2.41.
IMNM demonstrates positive technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for IMNM include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 49.9%. The stock shows neutral valuation indicators based on valuation analysis.
Analysis generated on November 2, 2025 at 04:24 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IMNM | $16.07 | +0.6% | 732.91K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |